Subscribe to our E-Newsletter

Stay up-to-date on the latest news about prostate cancer. Join our distribution list to receive periodic email updates and our monthly e-newsletter.

A Multi-Institutional Phase 2 Trial of Prostate Stereotactic Body Radiation Therapy (SBRT) Using Continuous Real-Time Evaluation of Prostate Motion with Patient-Reported Quality of Life

The use of stereotactic body radiation therapy (SBRT) for prostate cancer has been reported predominantly from single institutional studies, although concerns for broader adoption exist.

Read more.

source: Uro Today